32349249 35563876 32243786 33821751 32603815 35652098 34376056 35575684 34541453 34091053 35215971 35940643 32775493 32753732 33785374 34439845 31570731 32719823 33594520 34601132 36239875 36419469 35506982 33686777 32647121 33022212 34453943 3477887 - Search Results

Year	Number of Results
2019	3
2020	16
2021	20
2022	17
2023	0

1

Application of CRISPR Tools for Variant Interpretation and Disease Modeling in Inherited Retinal Dystrophies.

Fuster-García C, García-Bohórquez B, Rodríguez-Muñoz A, Millán JM, García-García G. Fuster-García C, et al. Genes (Basel). 2020 Apr 27;11(5):473. doi: 10.3390/genes11050473. Genes (Basel). 2020. PMID: 32349249 Free PMC article. Review.

2

Genetic Kidney Diseases (GKDs) Modeling Using Genome Editing Technologies.

Gómez-García F, Martínez-Pulleiro R, Carrera N, Allegue C, Garcia-Gonzalez MA. Gómez-García F, et al. Cells. 2022 May 6;11(9):1571. doi: 10.3390/cells11091571. Cells. 2022. PMID: 35563876 Free PMC article. Review.

3

CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors.

Wang D, Zhang F, Gao G. Wang D, et al. Cell. 2020 Apr 2;181(1):136-150. doi: 10.1016/j.cell.2020.03.023. Cell. 2020. PMID: 32243786 Free PMC article. Review.

4

CRISPR Cas9 based genome editing in inherited retinal dystrophies.

Bansal M, Acharya S, Sharma S, Phutela R, Rauthan R, Maiti S, Chakraborty D. Bansal M, et al. Ophthalmic Genet. 2021 Aug;42(4):365-374. doi: 10.1080/13816810.2021.1904421. Epub 2021 Apr 6. Ophthalmic Genet. 2021. PMID: 33821751 Review.

5

Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases.

Yu W, Wu Z. Yu W, et al. Adv Drug Deliv Rev. 2021 Jan;168:181-195. doi: 10.1016/j.addr.2020.06.011. Epub 2020 Jun 27. Adv Drug Deliv Rev. 2021. PMID: 32603815 Review.

6

From Bench to Bed: The Current Genome Editing Therapies for Glaucoma.

He M, Rong R, Ji D, Xia X. He M, et al. Front Cell Dev Biol. 2022 May 16;10:879957. doi: 10.3389/fcell.2022.879957. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35652098 Free PMC article. Review.

7

Allele-Specific Knockdown of Mutant Huntingtin Protein via Editing at Coding Region Single Nucleotide Polymorphism Heterozygosities.

Oikemus SR, Pfister EL, Sapp E, Chase KO, Kennington LA, Hudgens E, Miller R, Zhu LJ, Chaudhary A, Mick EO, Sena-Esteves M, Wolfe SA, DiFiglia M, Aronin N, Brodsky MH. Oikemus SR, et al. Hum Gene Ther. 2022 Jan;33(1-2):25-36. doi: 10.1089/hum.2020.323. Hum Gene Ther. 2022. PMID: 34376056 Free PMC article.

8

Cryo-electron Microscopy of Adeno-associated Virus.

Stagg SM, Yoshioka C, Davulcu O, Chapman MS. Stagg SM, et al. Chem Rev. 2022 Sep 14;122(17):14018-14054. doi: 10.1021/acs.chemrev.1c00936. Epub 2022 May 16. Chem Rev. 2022. PMID: 35575684 Free PMC article. Review.

9

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics.

Liu W, Li L, Jiang J, Wu M, Lin P. Liu W, et al. Precis Clin Med. 2021 Jul 10;4(3):179-191. doi: 10.1093/pcmedi/pbab014. eCollection 2021 Sep. Precis Clin Med. 2021. PMID: 34541453 Free PMC article. Review.

10

New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape.

van Hees M, Slott S, Hansen AH, Kim HS, Ji HP, Astakhova K. van Hees M, et al. Mol Ther. 2022 Jan 5;30(1):32-46. doi: 10.1016/j.ymthe.2021.06.003. Epub 2021 Jun 4. Mol Ther. 2022. PMID: 34091053 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results